Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daratumumab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients With De Novo Donor-Specific Antibodies: A Case-Control Study

NCT07081126 is registered in ClinicalTrials.gov with University Hospital, Martin as lead sponsor.

NCT NCT07081126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07081126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daratumumab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients With De Novo Donor-Specific Antibodies: A Case-Control Study
Lead sponsor
University Hospital, Martin
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2025
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute rejection (ar) of transplanted kidney, kidney tansplant